Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by langostaon Feb 25, 2019 9:59am
170 Views
Post# 29408357

RE:RE:We should keep in mind.....

RE:RE:We should keep in mind.....
tomchoco wrote: A very good friend of mine is the CEO of a biotech in Australia. He told me last week that writing a PR with predictions of future events is a thing of the past. A lawyer representing his company scrutinizes every line and basically makes him delete 1/2 the PR before it makes it's way to the public. Regulatory commissions and bitter shareholders will come down hard if you are wrong. Erring on the side of caution is smart now.


As it should be. Except of course if you are a mini hole in the ground gold mining company on the Vulture with paid pumping newsheet writers boosting the gravel content. Now that's where the Venture gets its upstanding reputation. (Sarcasm intended). :-) 

Bullboard Posts